Predictive value of the ERCC1 expression for treatment response and survival in advanced gastric cancer patients receiving cisplatin-based first-line chemotherapy.

导出 OA

翻译打印收藏纠错

作者： Jina,Yun ^[1] ; Kyoung-Mee,Kim ; Seung Tae,Kim ; Jung-Hoon,Kim ; Jung A,Kim ; Jee Hyun,Kong ; Soo Hyeon,Lee ; Young-Woong,Won ; Jong-Mu,Sun ; Jeeyun,Lee ; Se Hoon,Park ; Joon Oh,Park ; Young Suk,Park ; Ho Yeong,Lim ; Won Ki,Kang

作者单位： Department of Medicine, Sungkyunkwan University Samsung Medical Center, Seoul, Korea. ^[1]

关键词 Capecitabine Cisplatin ERCC1 Immunohistochemical stain Stomach neoplasms

DOI 10.4143/crt.2010.42.2.101

PMID 20622964

发布时间 2021-10-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览58

Cancer research and treatment

2010年42卷2期

101-6页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Predictive value of the ERCC1 expression for treatment response and survival in advanced gastric cancer patients receiving cisplatin-based first-line chemotherapy.

Cancer research and treatment

相似文献

Cancer research and treatment

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Predictive value of the ERCC1 expression for treatment response and survival in advanced gastric cancer patients receiving cisplatin-based first-line chemotherapy.

Cancer research and treatment

相似文献

Cancer research and treatment

相关期刊

检索历史清除